A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial

@article{Heijnen2007AMT,
  title={A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial},
  author={Esther Heijnen and Marinus J. C. Eijkemans and Cora de Klerk and Suzanne Polinder and Nicole G M Beckers and Ellen R. Klinkert and Frank J M Broekmans and Jan Passchier and Egbert R. te Velde and Nicholas S. Macklon and Bart C. J. M. Fauser},
  journal={The Lancet},
  year={2007},
  volume={369},
  pages={743-749}
}

Figures and Tables from this paper

Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint.

TLDR
It is unlikely, over a wide range of society's willingness-to-pay, that the standard treatment strategy is cost-effective, compared with the mild strategy, despite an increased mean number of IVF cycles within 1 year.

Mild Ovarian Stimulation for in vitro Fertilization: Are We Ready to Change? A Meta-Analysis

TLDR
This analysis presents strong evidence in favour of conventional stimulation IVF, which therefore should currently be considered a treatment of choice for patients requiring IVF treatment.

Minimal stimulation IVF vs conventional IVF: a randomized controlled trial.

MINIMAL STIMULATION IN VITRO FERTILIZATION: A BETTER OUTCOME (COMMENTARY)

TLDR
A lack of robust outcome data can assure the success of mild-IVF at least as good as those of conventional IVF, and the treatment outcomes of in all age-groups were comparable with those in the Registry of the Society for Assisted Reproduction (SART) in the USA.

Mild stimulation for in vitro fertilization.

Potential Benefit of Mild Stimulation Regimen on Embryo Quality in IVF- ICSI Cycles

TLDR
In a specific subgroup of women with poor embryo quality following conventional IVF-ICSI protocols, a mild stimulation regimen seems to improve embryo quality.

Comparison of mild stimulation and conventional stimulation in ART outcome

TLDR
Clomiphene +-delayed low dose gonadotropin + flexible GnRH − antagonist stimulation is an acceptable alternative protocol for IVF in patients with regularly menstruation.

[Use of GnRH antagonist for in vitro fertilization].

  • E. Ekerhovd
  • Medicine, Biology
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
  • 2011
TLDR
Stimulation with a GnRH-antagonist instead of a Gn RH-agonist in IVF, is less physically and psychologically demanding for the patients and maintains the same birth rate.

COMPARISON OF THE INFLUENCE OF DIFFERENT OVULATION INDUCTION PROTOCOLS ON CUMULATIVE PREGNANCY RATES IN AN IVF / ET PROGRAM

TLDR
Mild ovarian stimulation proved to be equally successful in achieving clinical pregnancy as the standard ovarian stimulation in patients in whom the ovulation induction was conducted in a modified natural cycle and in cycles with mild andstandard ovarian stimulation.
...

References

SHOWING 1-10 OF 31 REFERENCES

Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: methodological considerations on a randomized controlled non-inferiority trial.

TLDR
This effectiveness study applies an integrated medical, health economics and psychological approach with term live birth over a given period of time after starting IVF as the end-point and vindicates many of the design decisions.

Two cycles with single embryo transfer versus one cycle with double embryo transfer: a randomized controlled trial.

TLDR
Two cycles with SET were equally effective as one cycle with DET, and the medical costs per live birth up to 6 weeks after delivery were the same, however, if lifetime costs for severe handicaps are included, more than 7000 perLive birth will be saved after implementing SET.

Cost-effectiveness analysis of in-vitro fertilization: estimated costs per successful pregnancy after transfer of one or two embryos.

TLDR
IVF costs are the sum of fertilization treatment costs and the costs for health care of the pregnant women and their offspring and the lower twin pregnancy rate of the former approach caused it to be more cost-efficient than the latter.

Number of embryos for transfer after IVF and ICSI: a Cochrane review.

TLDR
Single embryo transfer significantly reduces the risk of multiple pregnancy, but also decreases the chance of live birth in a fresh IVF cycle, and subsequent replacement of a single frozen embryo achieves a live birth rate comparable with double embryo transfer.

Randomized single versus double embryo transfer: obstetric and paediatric outcome and a cost-effectiveness analysis.

TLDR
The SET strategy is superior to the DET strategy, when number of deliveries with at least one live-born child, incremental cost-effectiveness ratio and maternal and paediatric complications are taken into consideration.

Single embryo transfer and IVF/ICSI outcome: a balanced appraisal.

  • J. Gerris
  • Medicine
    Human reproduction update
  • 2005
TLDR
To make SET the standard of care in the appropriate target group, there is a need for more clinical studies, for intensive counselling of patients, and for an increased sense of responsibility in patients, health care providers and health insurers.

The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF.

TLDR
During the first IVF treatment cycle, mild ovarian stimulation and SET does not lead to more psychological complaints than conventional IVF.

Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization

TLDR
In women under 36 years of age, transferring one fresh embryo and then, if needed, one frozen-and-thawed embryo dramatically reduces the rate of multiple births while achieving a rate of live births that is not substantially lower than the rate that is achievable with a double-embryo transfer.

Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment?

TLDR
After introducing a SET policy, the expected decline of twinning was met at an unchanged clinical pregnancy rate, and the SET legislation had no negative consequences for the couples.